• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

mRNA 疫苗接种:固有感应和适应性免疫反应的展望。

mRNA Vaccination: An Outlook on Innate Sensing and Adaptive Immune Responses.

机构信息

Department of Pathobiology, Ontario Veterinary College, University of Guelph, Guelph, ON N1G 2W1, Canada.

出版信息

Viruses. 2024 Sep 1;16(9):1404. doi: 10.3390/v16091404.

DOI:10.3390/v16091404
PMID:39339880
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11437395/
Abstract

Vaccination has led to significant dismantling of infectious diseases worldwide. Since the dawn of the SARS-CoV-2 pandemic, there has been increased popularity in the usage and study of the mRNA vaccine platform. Here, we highlight fundamental knowledge on mRNA vaccine pharmacology, followed by the immunity conferred by innate sensing and adaptive responses resulting from exposure to the mRNA vaccine construct and encapsulation materials. A better understanding of these immune mechanisms will shed light on further improvements in mRNA vaccine design, aiming to improve efficiency and optimize immune responses upon inoculation.

摘要

疫苗接种已在全球范围内显著消除了传染病。自 SARS-CoV-2 大流行开始以来,mRNA 疫苗平台的使用和研究日益普及。在这里,我们重点介绍 mRNA 疫苗药理学的基础知识,然后介绍先天感应和适应性反应所赋予的免疫力,这些反应是由于暴露于 mRNA 疫苗构建体和封装材料引起的。更好地了解这些免疫机制将有助于进一步改进 mRNA 疫苗设计,旨在提高接种效率和优化免疫反应。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47a6/11437395/3d1743ba0246/viruses-16-01404-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47a6/11437395/3c4b811688b6/viruses-16-01404-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47a6/11437395/3d1743ba0246/viruses-16-01404-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47a6/11437395/3c4b811688b6/viruses-16-01404-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47a6/11437395/3d1743ba0246/viruses-16-01404-g002.jpg

相似文献

1
mRNA Vaccination: An Outlook on Innate Sensing and Adaptive Immune Responses.mRNA 疫苗接种:固有感应和适应性免疫反应的展望。
Viruses. 2024 Sep 1;16(9):1404. doi: 10.3390/v16091404.
2
Modulation of innate immune response to mRNA vaccination after SARS-CoV-2 infection or sequential vaccination in humans.SARS-CoV-2 感染后或序贯接种 mRNA 疫苗对人体固有免疫反应的调节。
JCI Insight. 2024 May 8;9(9):e175401. doi: 10.1172/jci.insight.175401.
3
mRNA vaccines contribute to innate and adaptive immunity to enhance immune response in vivo.mRNA 疫苗有助于先天和适应性免疫,增强体内免疫反应。
Biomaterials. 2024 Oct;310:122628. doi: 10.1016/j.biomaterials.2024.122628. Epub 2024 May 28.
4
MVA-based SARS-CoV-2 vaccine candidates encoding different spike protein conformations induce distinct early transcriptional responses which may impact subsequent adaptive immunity.编码不同刺突蛋白构象的基于MVA的新型冠状病毒2型候选疫苗可诱导不同的早期转录反应,这可能会影响随后的适应性免疫。
Front Immunol. 2024 Dec 19;15:1500615. doi: 10.3389/fimmu.2024.1500615. eCollection 2024.
5
mRNA Vaccines: Design Principles, Mechanisms, and Manufacturing-Insights From COVID-19 as a Model for Combating Infectious Diseases.mRNA疫苗:设计原理、作用机制及生产——以COVID-19作为抗击传染病模型的见解
Biotechnol J. 2025 Feb;20(2):e202400596. doi: 10.1002/biot.202400596.
6
A promising mRNA vaccine derived from the JN.1 spike protein confers protective immunity against multiple emerged Omicron variants.一种源自JN.1刺突蛋白的很有前景的mRNA疫苗可针对多种已出现的奥密克戎变体提供保护性免疫。
Mol Biomed. 2025 Mar 4;6(1):13. doi: 10.1186/s43556-025-00258-7.
7
High-Resolution Linear Epitope Mapping of the Receptor Binding Domain of SARS-CoV-2 Spike Protein in COVID-19 mRNA Vaccine Recipients.新型冠状病毒刺突蛋白受体结合域线性表位在 COVID-19 mRNA 疫苗接种者中的高分辨率线性表位作图。
Microbiol Spectr. 2021 Dec 22;9(3):e0096521. doi: 10.1128/Spectrum.00965-21. Epub 2021 Nov 10.
8
Antibody and T cell immune responses following mRNA COVID-19 vaccination in patients with cancer.癌症患者接种新冠病毒mRNA疫苗后的抗体和T细胞免疫反应。
Cancer Cell. 2021 Aug 9;39(8):1034-1036. doi: 10.1016/j.ccell.2021.07.016. Epub 2021 Jul 27.
9
Engineering mRNA vaccine with broad-spectrum protection against SARS-cov-2 variants.设计具有针对SARS-CoV-2变体的广谱保护作用的mRNA疫苗。
Biochem Biophys Res Commun. 2025 Feb;746:151224. doi: 10.1016/j.bbrc.2024.151224. Epub 2024 Dec 25.
10
Innate immune responses to three doses of the BNT162b2 mRNA SARS-CoV-2 vaccine.三种剂量 BNT162b2 mRNA SARS-CoV-2 疫苗的先天免疫应答。
Front Immunol. 2022 Aug 22;13:947320. doi: 10.3389/fimmu.2022.947320. eCollection 2022.

引用本文的文献

1
[Platform technologies in vaccine development].[疫苗研发中的平台技术]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2025 Apr;68(4):368-377. doi: 10.1007/s00103-025-04024-6. Epub 2025 Mar 4.

本文引用的文献

1
Fluorinated Lipid Nanoparticles for Enhancing mRNA Delivery Efficiency.氟化脂质纳米颗粒用于提高 mRNA 递送效率。
ACS Nano. 2024 Mar 19;18(11):7825-7836. doi: 10.1021/acsnano.3c04507. Epub 2024 Mar 7.
2
Evaluation of the Immunological Efficacy of an LNP-mRNA Vaccine Prepared from Varicella Zoster Virus Glycoprotein gE with a Double-Mutated Carboxyl Terminus in Different Untranslated Regions in Mice.评估由水痘带状疱疹病毒糖蛋白gE制备的、羧基末端在不同非翻译区具有双突变的LNP-mRNA疫苗在小鼠中的免疫效果。
Vaccines (Basel). 2023 Sep 11;11(9):1475. doi: 10.3390/vaccines11091475.
3
The impact of nucleoside base modification in mRNA vaccine is influenced by the chemistry of its lipid nanoparticle delivery system.
信使核糖核酸(mRNA)疫苗中核苷酸碱基修饰的影响受其脂质纳米颗粒递送系统化学性质的影响。
Mol Ther Nucleic Acids. 2023 May 8;32:794-806. doi: 10.1016/j.omtn.2023.05.004. eCollection 2023 Jun 13.
4
A reverse vaccinology approach to design an mRNA-based vaccine to provoke a robust immune response against HIV-1.一种反向疫苗学方法,用于设计基于 mRNA 的疫苗,以引发针对 HIV-1 的强大免疫反应。
Acta Biochim Pol. 2023 Jun 17;70(2):407-418. doi: 10.18388/abp.2020_6696.
5
Expression Improvement of Recombinant Plasmids of the Interleukin-7 Gene in Chitosan-Derived Nanoparticles and Their Elevation of Mice Immunity.白细胞介素-7基因重组质粒在壳聚糖衍生纳米颗粒中的表达改善及其对小鼠免疫力的提升
Biology (Basel). 2023 Apr 28;12(5):667. doi: 10.3390/biology12050667.
6
Algorithm for optimized mRNA design improves stability and immunogenicity.优化 mRNA 设计的算法可提高稳定性和免疫原性。
Nature. 2023 Sep;621(7978):396-403. doi: 10.1038/s41586-023-06127-z. Epub 2023 May 2.
7
Spleen-selective co-delivery of mRNA and TLR4 agonist-loaded LNPs for synergistic immunostimulation and Th1 immune responses.脾脏选择性共递 mRNA 和 TLR4 激动剂负载的 LNPs 以协同免疫刺激和 Th1 免疫应答。
J Control Release. 2023 May;357:133-148. doi: 10.1016/j.jconrel.2023.03.041. Epub 2023 Mar 29.
8
STING Agonist-Derived LNP-mRNA Vaccine Enhances Protective Immunity Against SARS-CoV-2.STING 激动剂衍生的 LN P-mRNA 疫苗增强了对 SARS-CoV-2 的保护性免疫。
Nano Lett. 2023 Apr 12;23(7):2593-2600. doi: 10.1021/acs.nanolett.2c04883. Epub 2023 Mar 21.
9
Hepatitis C virus E1 and modified E2 delivered from an mRNA vaccine induces protective immunity.从一种mRNA疫苗递送的丙型肝炎病毒E1和修饰的E2可诱导保护性免疫。
NPJ Vaccines. 2023 Mar 18;8(1):42. doi: 10.1038/s41541-023-00635-9.
10
Bioinformatics Designing and Molecular Modelling of a Universal mRNA Vaccine for SARS-CoV-2 Infection.针对SARS-CoV-2感染的通用mRNA疫苗的生物信息学设计与分子建模
Vaccines (Basel). 2022 Dec 9;10(12):2107. doi: 10.3390/vaccines10122107.